Sign in
4

Changes in Ownership

Dianthus Therapeutics, Inc. /DE/ Filed Acc 0001992324-26-000006

EVP, CFO & CBO sold 8,224 shares at $89.84 ($738,844)

  • EVP, CFO & CBO acquired 8,224 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Savitz Ryan EVP, CFO & CBO 2026-04-09 Option exercise 10b5-1 +8,224 $17.88 $147,045 8,224 D
Savitz Ryan EVP, CFO & CBO 2026-04-09 Sale 10b5-1 −8,224 $89.84 $738,844 0 D
Derivatives
Savitz Ryan EVP, CFO & CBO 2026-04-09 Option exercise · Stock Option (Right to Buy) 10b5-1 −8,224 71,776 D
Open-market sales · 8,224 sh · avg $89.84 · $738,844
Loading xslF345X06/ownership.xml…